APOA1 and ischemic stroke: Elevated levels of ApoA-I have been consistently associated with a reduced risk of ischemic stroke, likely due to its capacity to promote RCT, reduce oxidative stress, and inhibit inflammatory pathways, key mechanisms that contribute to atherosclerotic plaque stabilization and vascular health [134].